“Prioritizing nanotechnology risk research isn’t rocket science,” said Project on Emerging Nanotechnologies chief scientist Andrew Maynard. Dr. Maynard’s remark is in his testimony today before the federal government’s first public meeting focused exclusively on research needs and priorities for the environmental, health and safety risks of engineered nanoscale materials.
Research led by a team from UAB (University of Alabama at Birmingham) has shown that a dopamine agonist called rotigotine could be effective in treating symptoms of Parkinson?s disease (PD). In a study published Jan. 3 in the online edition of Neurology, rotigotine significantly improved symptoms in patients with early-stage PD.
The collaborative work being performed by professionals across medical disciplines in the promising area of molecular imaging — from research scientists to nuclear medicine physicians, urologists, radiochemists and even veterinarians — provides encouraging news in fighting prostate cancer. This type of progressive — or translational — research can be seen in two papers published in the January issue of the Journal of Nuclear Medicine.
Infection with the human papilloma virus, the major cause of cervical cancer, is forever. The virus remains latent in skin cells, ready to flare up at any time to create warts on the skin or the genitals. A new finding by UC Berkeley’s Michael Botchan and colleagues offers hope that a drug can halt spread of the virus into new cells, and perhaps even eliminate the virus from the body.
To eliminate tuberculosis (TB) in the United States, current guidelines should be changed to reclassify all foreign-born residents from high incidence countries as “high-risk” regardless of the amount of time they have lived in the US.
Scientists at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health in Bethesda, Md., and colleagues at the University of Virginia in Charlottesville have succeeded in imaging, in unprecedented detail, the virus that causes influenza.
Medical teams — not individuals — are critical to the prevention of catheter-related bloodstream infections, as well as for the overall health, safety, and welfare of patients, according to an editorial by two Virginia Commonwealth University physicians published in today’s issue of the New England Journal of Medicine.
Experiments indicate the promise of imatinib mesylate to prevent tissue fibrosis and bring meaningful advances to the treatment of SSc.
Researchers at the National Institutes of Health have discovered that a previously unexplained fatal form of Osteogenesis Imperfecta — a disorder that weakens bones and which may cause frequent fractures — results from a genetic defect in a protein involved in the production of collagen.
Hospitals will quickly slash the rate of common, costly and potentially lethal catheter-related bloodstream infections in their intensive care units (ICUs) by using cheap, low-tech, common-sense measures like hand washing, timely removal of unneeded catheters and use of sites other than the groin to place lines when possible, according to a report from safety experts at Johns Hopkins in the Dec. 28 issue of the New England Journal of Medicine.